血红蛋白与常见恶性瘤风险之间的相关性:1999-2020年后期分析和因果关联分析
Guo-Sheng Li1, Tao Huang2, Jing-Xiao Li1
1Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, P. R. China.
BMC cancer
|June 21, 2024
概括
高血红蛋白 (HGB) 水平显示出对前列腺癌 (PRCA) 发生和预后的保护作用. 这一发现为癌症风险和患者的结果提供了新的见解.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
背景情况:
- 血红蛋白 (HGB) 水平与常见恶性瘤的风险之间的关联尚未得到充分证实.
- 了解这种关系对于癌症风险评估和管理至关重要.
研究的目的:
- 研究血红蛋白水平与15种常见恶性瘤的风险之间的相关性.
- 评估HGB水平与前列腺癌 (PRCA) 风险和预后之间的因果关系.
主要方法:
- 追溯分析50 085个国家健康和营养检查调查样本.
- 门德尔的随机化分析 (MRAs) 使用来自超过70万个样本的全基因组关联研究数据.
- 在56个内部样本上对PRCA预后进行卡普兰-梅尔曲线分析.
主要成果:
- 升高的HGB水平与宫癌,黑色素瘤和非黑色素瘤皮肤癌的风险增加有关.
- HGB与结肠癌,食道癌,胃癌,骨癌,肺癌,癌和前列腺癌具有保护性关联.
- MRAs表示高HGB水平降低PRCA风险 (OR=0.869,p<0.05);内部数据证实高HGB与更好的PRCA预后相关 (p<0.05).
结论:
- 循环中的高血红蛋白水平似乎是预防前列腺癌发展的保护因素.
- 升高的HGB水平可能在PRCA的良好预后中发挥重要作用.
相关概念视频
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Hazard Ratio
111
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
111
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Statistical Methods for Analyzing Epidemiological Data
349
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
349
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K


